Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AK106-001616 in Rheumatoid Arthritis
NCT00902369Phase 2Completed
- Sponsor
- Asahi Kasei Corporation
- Start
- May 2009
- Primary completion
- Oct 2009
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 2 trial of AK106-001616 in rheumatoid arthritis (RA), sponsored by Asahi Kasei Corporation. Started May 2009; status: completed.
02
Drugs
AK106-001616
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00902369.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00902369.